Teladoc Health Redefines Virtual Healthcare With Explosive Engagement & Market Expansion!

Teladoc Health, Inc. concluded 2024 with mixed financial and operational outcomes while emphasizing execution against its core strategic priorities. The company generated full-year revenue of $2.6 billion, a 1% decline compared to 2023, primarily due to challenges in its BetterHelp segment. However, adjusted EBITDA rose to $311 million, reflecting a 12.1% margin, supported by cost savings and productivity initiatives. Free cash flow was $170 million, and Teladoc ended the year with $1.3 billion in cash and equivalents. Net loss per share was $5.87, largely influenced by a non-cash goodwill impairment of $4.63 per share.